Modernizing a compliance program means bringing all of the relevant knowledge under a single technological roof. The key to leveraging data in a holistic manner is recognition that these disparate sets of information aren’t mere byproducts of compliance management. Rather, all this amassed information is a singular resource that can and should be leveraged for competitive gains.

Aside from the compliance benefits, centralized and standardized HCP engagement and spending data forms the foundation of a cohesive predictive action plan. HCP engagement risk is still a top risk for life sciences, so drug, device and biologics manufacturers need a platform backed by consultative excellence that facilitates best-practice optimization in advance of development and deployment. Companies benefit when AI-assisted analytics alert the compliance department to future potential red flags, which enables strategic deployment of limited resources to emerging risk areas.

In order for compliance programs to succeed, the implementation and execution of human data science must be seamless, aligning with business processes to ensure both initial adoption and ongoing adherence. A lack of utilization leads to a lack of data—diminishing system value. Usability of platforms must be a key consideration prior to implementation.

Empower compliance teams to optimize performance by adopting a risk-based approach to monitoring engagement as follows:

1. Standardize data collection and reporting: This process is a key step towards reducing the risk of ToV errors, and reconciling the number and type of HCP interactions—across therapeutic practice areas and all along the spectrum of promotional activities.

2. Improve the end-user experience: Improve relationships with your HCP audience and your KOLs by delivering a simple, user-friendly experience. A nimble, responsive interface increases user adoption. HCPs will have a better and more seamless experience, and companies will better synchronize both their touchpoint management and their compliance oversight. This allows organizers of promotional speaker series, grant programs, field reps and other stakeholders to all operate autonomously while simultaneously implementing compliance.

3. Create internal efficiencies: The industry needs connected data — not just to avoid regulatory violations, but in order to streamline and optimize business operations. By improving the data capture process, an initial engagement yields higher-quality data that facilitates more accurate downstream reporting. This, in turn, delivers cohesive, high quality risk mitigation and real-time compliance monitoring.

4. Mitigate risk: Even “modern” compliance infrastructure is often a patchwork of disparate tools and systems — which is an open-ended conduit for risk. The more fragmented the operational structure, the more likely it is that HCP engagements will fall through the cracks or not be appropriately categorized; or that ToV will be incompletely or incorrectly calculated, or that HCPs will have to wade through multiple platforms — even when performing activities for the same company. 𠊎mbedded within IQVIA HCP/O Engagement Management, automated risk scoring and compliance monitoring educates the end user of relevant compliance boundaries — a capability which frees up bandwidth, both mitigating risk and enabling more time for strategic pursuits.

5. Achieve master data management: Piecemeal efforts at compliance management can have tangible detrimental effects on the business bottom line and inflate opportunity costs that can erode morale and management support. A system that is fluent in the “language” of both traditional and non-traditional data can be the catalyst for more nimble, responsive operational protocols.

6. Transition from process to project: An integrated, four-pronged strategic framework creates strength without unnecessary redundancy to ensure that every activity is filtered through an accurately deployed system of checks and balances for targeted risk oversight:

• Create a “30,000-foot” view with an integrated monitoring dashboard that presents cohesive insight across therapeutic areas, field teams’ HCP touchpoints and activities pertaining to patient assistance. To keep information both high-level and accessible, insights extracted and extrapolated from the data should be rendered in graphic format to make key activity risk indicators immediately actionable.
• Implement live in-person monitoring to facilitate real-time oversight of a risk-targeted sample of business activity that can be overseen by an internal or external monitor.
• Use desktop monitoring and transaction review checks for alignment of policies and protocols pertaining to HCP engagement rules, aggregate and individual spending limits and ToV documentation and reconciliation.
• Expand the use and applications of data to proactively identify non-compliance trends and focus areas for monitoring. The use of data-enhanced risk identification enables access to highly granular information from nontraditional sources.

The ultimate outcome is integration of silo-inclusive monitoring results facilitated by IQVIA’s human data science infrastructure. Deploying AI-enhanced technology increases the agility and responsiveness of commercial compliance, facilitating optimized resource allocation and improving return on investment.

To learn more about our solutions, and how connected intelligence can deliver valuable insight from compliance data, download our newest white paper here:
Turn Insight into Action with Connected Intelligence